References
- Fratiglioni L, De Ronchi D, Aguero-Torres H. Worldwide prevalence and incidence of dementia. Drugs Aging 1999; 15(5): 365–75
- Ott A, Breteler MM, van Harskamp F, et al. Prevalence of Alzheimer's disease and vascular dementia: association with education. The Rotterdam study. BMJ 1995; 310(6985): 970–3
- McDowell I. Alzheimer's disease: insights from epidemiology. Aging (Milano) 2001; 13(3): 143–62
- Bennett D. Public health importance of vascular dementia and Alzheimer's disease with cerebrovascular disease. Int J Clin Pract Suppl 2001; 120: 41–8
- Wolfson C, Wolfson DB, Asgharian M, et al; Clinical Progression of Dementia Study Group. A reevaluation of the duration of survival after the onset of dementia. N Engl J Med 2001; 344(15): 1111–6
- Knopman DS, DeKosky ST, Cummings JL, et al. Practice parameter: diagnosis of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2001; 56(9): 1143–53
- Pohjasvaara T, Mantyla R, Ylikoski R, et al. Comparison of different clinical criteria (DSM-III, ADDTC, ICD-10, NINDS-AIREN, DSM-IV) for the diagnosis of vascular dementia. National Institute of Neurological Disorders and Stroke—Association Internationale pour la Recherche et I'Enseignement en Neurosciences. Stroke 2000; 31(12): 2952–7
- Kalaria RN. The role of cerebral ischemia in Alzheimer's disease. Neurobiol Aging 2000; 21(2): 321–30
- Snowdon DA, Greiner LH, Mortimer JA, et al. Brain infarction and the clinical expression of Alzheimer disease. The Nun Study. JAMA 1997; 277(10): 813–7
- Sachdev PS, Brodaty H, Looi JC. Vascular dementia: diagnosis, management and possible prevention. Med J Aust 1999; 170(2): 81–5
- Ruitenberg A, Ott A, van Swieten JC, et al. Incidence of dementia: Does gender make a difference? Neurobiol Aging 2001; 22(4): 575–80
- in't Veld BA, Ruitenberg A, Hofman A, et al. Antihypertensive drugs and incidence of dementia: the Rotterdam Study. Neurobiol Aging 2001; 22(3): 407–12
- Luchsinger JA, Tang MX, Stern Y, et al. Diabetes mellitus and risk of Alzheimer's disease and dementia with stroke in a multiethnic cohort. Am J Epidemiol 2001; 154(7): 635–41
- Kimura S, Saito H, Minami M, et al. Pathogenesis of vascular dementia in stroke-prone spontaneously hypertensive rats. Toxicology 2000; 153 (1–3): 167–78
- Gottfries CG, Blennow K, Karlsson I, et al. The neurochemistry of vascular dementia. Dementia 1994; 5(3–4): 163–7
- Tohgi H, Abe T, Kimura M, et al. Cerebrospinal fluid acetylcholine and choline in vascular dementia of Binswanger and multiple small infarct types as compared with Alzheimer-type dementia. J Neural Transm 1996; 103(10): 1211–20
- Swartz RH, Sahlas DJ, Black SE. Strategic involvement of cholinergic pathways and executive dysfunction: Does location of white matter signal hy- perintensities matter? J Stroke Cerebrovasc Dis 2003; 12(1): 29–36
- Johannsen P. Long-term Cholinesterase inhibitor treatment of Alzheimer's disease. CNS Drugs 2004; 18(12): 757–68
- Moretti R, Torre P, Antonello RM, et al. Rivastigmine in subcortical vascular dementia: a randomized, controlled, open 12-month study in 208 patients. Am J Alzheimers Dis Other Demen 2003; 18(5): 265–72
- Erkinjuntti T, Kurz A, Gauthier S, et al. Efficacy of galantamine in probable vascular dementia and Alzheimer's disease combined with cerebrovascular disease: a randomised trial. Lancet 2002; 359(9314): 1283–90
- Wilkinson D, Doody R, Helme R, et al; Donepezil 308 Study Group. Donepezil in vascular dementia: a randomized, placebo-controlled study. Neurology 2003; 61(4): 479–86
- Black S, Roman GC, Geldmacher DS, et al; Donepezil 307 Vascular Dementia Study Group. Efficacy and tolerability of donepezil in vascular dementia: positive results of a 24-week, multicenter, international, randomized, placebo-controlled clinical trial. Stroke 2003; 34(10): 2323–30
- Perdomo C, Pratt R. Donepezil provides significant benefits in patients with vascular dementia. (Abstr) J Neuropsych Clin Neurosci 2003; 15(2): 271–2